Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib.

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
30 May 2024
Historique:
received: 13 02 2024
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 30 5 2024
Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2024.285146 PMID: 38813710
pubmed: 38813710
doi: 10.3324/haematol.2024.285146
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Zachary Risch (Z)

The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology/Medical Oncology.

Benjamin H Kaffenberger (BH)

The Ohio State University Wexner Medical Center, Department of Dermatology.

Catherine G Chung (CG)

The Ohio State University Wexner Medical Center, Department of Pathology.

Eric Samorodnitsky (E)

The Ohio State University James Comprehensive Cancer Center.

Emily L Hoskins (EL)

The Ohio State University James Comprehensive Cancer Center; The Ohio State University Biomedical Sciences Graduate Program.

Thuy Dao (T)

The Ohio State University James Comprehensive Cancer Center.

Amy Smith (A)

The Ohio State University James Comprehensive Cancer Center.

Sarah A Wall (SA)

The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology/Medical Oncology.

Jonathan Brammer (J)

The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology/Medical Oncology.

Julie W Reeser (JW)

The Ohio State University James Comprehensive Cancer Center.

Michele R Wing (MR)

The Ohio State University James Comprehensive Cancer Center.

Julia F Hopkins (JF)

Foundation Medicine Inc..

Lee A Albacker (LA)

Foundation Medicine Inc..

Lynne V Abruzzo (LV)

The Ohio State University Wexner Medical Center, Department of Pathology.

Caprice D Eisele (CD)

The Ohio State University Wexner Medical Center, Department of Pathology; The Ohio State University James Comprehensive Cancer Center; The Ohio State University Biomedical Sciences Graduate Program.

Aharon G Freud (AG)

The Ohio State University Wexner Medical Center, Department of Pathology.

Sameek Roychowdhury (S)

The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Medical Oncology. sameek.roychowdhury@osumc.edu.

Katherine E Walsh (KE)

Vanderbilt University Medical Center, Department of Internal Medicine, Division of Hematology/Oncology.

Classifications MeSH